COMPANY NAME	REVENUES 12 Months Ending Q3 2026	MARKET SHARE 12 Months Q3 2026	MARKET SHARE MRQ Q3 2026	MARKET SHARE A Quarter Before Q2 2026
Tarsus Pharmaceuticals Inc	682.20	4.41%	4.91 %	4.69 %
Viatris Inc	14,737.30	95.23%	94.74%	94.91%
Aldeyra Therapeutics Inc	0.00	0.00%	0.00%	0.00%
Eyepoint Inc	2.79	0.02%	0.01%	0.02%
Ocular Therapeutix Inc	50.38	0.33%	0.32%	0.36%
Harvard Apparatus Regenerative Technology Inc	0.89	0.01%	0.01%	0.01%

1 more competitors available

TARS's Market share relative to its competitors, as of Q3 2026 within the Healthcare Sector

As of Q3 2026

COMPANY NAME	MARKET SHARE 12 Months Ending Q3 2026	MARKET SHARE 12 Months Ending Q2 2026	MARKET SHARE MRQ Q3 2026	MARKET SHARE Q2 2026
Tarsus Pharmaceuticals Inc	4.41%	3.16%	4.91 %	4.69 %
Viatris Inc	95.23%	96.27%	94.74%	94.91%
Aldeyra Therapeutics Inc	0.00%	0.00%	0.00%	0.00%
Eyepoint Inc	0.02%	0.21%	0.01%	0.02%
Ocular Therapeutix Inc	0.33%	0.35%	0.32%	0.36%
Harvard Apparatus Regenerative Technology Inc	0.01%	0.00%	0.01%	0.01%

1 more companies available

Note: Market share is calculated based on total revenue. To get a more accurate picture of Tarsus Pharmaceuticals Inc's market divisions, geographic dispersion, segments, products, and services, visit Tarsus Pharmaceuticals Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.